BrightGene Public
BrightGene Bio-medical technology Co.,Ltd., is a leading Chinese biopharmaceutical company in small molecules and nucleotide drugs areas. Advised by China-based venture capital fund Laurel Venture Capital, BrightGene invests in all stage therapeutics and innovations.
Industry:
PharmTech
Headquarters:
Suzhou, Jiangsu, China
Founded Date:
2001
Investor Type:
Venture Funds